(Taken from the application) This core in the previous funding period was called as Sub-Cellular Organelle Core. In the current application, the core has been restructured and renamed. The two components are 1. The objectives of the Subcellular-Organelle are to 1. isolate, purify, quality test/assure and provide highly purified subcellular fractions and organelles, such as membrane vesicles and mitochondria, from rat livers, as well as parenchymal cells, as needed, 2. utilize techniques for further assessment of purity and/or purification if fractions using most modern methods such as two-phase partitioning and/or two- dimensional fractionation techniques, verifying and extending their findings with subcellular fractions and organelles to a more physiological model, the intact organ, 4. provide consultation and advice to investigators, regarding design, analysis and interpretation of kinetic transport studies and data, and 5. foster interdisciplinary collaboration and growth. The objectives of the Confocal Microscopy Subcore are to 1. provide services and technical expertise needed by a large number of independently funded investigators, and 2. foster interdisciplinary collaboration.

Project Start
2000-05-15
Project End
2001-02-28
Budget Start
Budget End
Support Year
6
Fiscal Year
2000
Total Cost
$425,000
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Chang, Huiyi H; Yeh, Jih-Chao; Ichiyama, Ronaldo M et al. (2018) Mapping and neuromodulation of lower urinary tract function using spinal cord stimulation in female rats. Exp Neurol 305:26-32
Chen, Chien-Yu; Chen, Jingyu; He, Lina et al. (2018) PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne) 9:338
Nakamura, Brooke N; Glazier, Alison; Kattah, Michael G et al. (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13:e0195893
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Wu, Raymond; Murali, Ramachandran; Kabe, Yasuaki et al. (2018) Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. Hepatology 68:1726-1740
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2018) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol 141:1147-1151.e8
Edman, Maria C; Janga, Srikanth R; Meng, Zhen et al. (2018) Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients. Sci Rep 8:11044
Baulies, Anna; Montero, Joan; Matías, Nuria et al. (2018) The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol 14:164-177
Ju, Yaping; Janga, Srikanth Reddy; Klinngam, Wannita et al. (2018) NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis. Exp Eye Res 176:243-251
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184

Showing the most recent 10 out of 449 publications